Login
Rafael Holdings NYSE: RFL
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
| Name | Rafael Holdings |
| Ticker | RFL |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
| Price | 16.94 |
| 52W Low/High | 10.40 / 22.58 |
| Market cap | 268 M |
| 1Y Total Return |
-12.14%
Average |
| 1Y Volatility |
87.51%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
Details
| Ticker | RFL |
| Name | Rafael Holdings |
| ISIN | US75062E1064 |
| CUSIP | 75062E106 |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
| Country | USA |
| Currency | U.S. Dollar |
Share as of 10/23/20
| Close Price | 16.94 |
| 52W Low/High | 10.40 / 22.58 |
| Market cap | 268 M |
| 1Y Total Return |
-12.14%
Average |
| 1Y Volatility |
87.51%
High Risk |
| Beta | 1.78 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -141.9% |
| Cash from Op. / Cur. Liabilities | -2.40 |
| Diluted Earnings / Share | -0.48 |
| ROE | - |
| ROIC | -5.1% |
| Price / Revenue | 52.8 |
| Price / Book | 2.2 |
| Price / CF | -75.1 |
| Current Ratio | 6.2 |
| Cur.Liabilities / Tot.Liabilities | 0.9 |
| Financial Leverage | 0.00 |
| in Mils USD |
rolling-year up to March
|
||||
|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | |
| Revenue |
5
|
5
|
-
|
-
|
|
| Gross Profit |
5
|
5
|
-
|
-
|
|
| R&D |
1
|
2
|
-
|
-
|
|
| EBITDA |
-5
|
-2
|
-
|
-
|
|
| Operating Income |
-8
|
-5
|
-
|
-
|
|
| Net Income exc. Extra |
-
|
-
|
-
|
-
|
|
| per Share | |||||
| Diluted avg Shares |
16
|
14
|
-
|
-
|
|
| EPS exc. Extra |
-0.48
|
-0.29
|
-
|
-
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
| Total Assets |
137
|
143
|
115
|
-
|
|
| Cash, Eq & Invt ShortTerm |
8
|
13
|
42
|
-
|
|
| Total Current Assets |
9
|
15
|
44
|
-
|
|
| Total Non-Current Assets |
128
|
129
|
71
|
-
|
|
| Intangibles |
2
|
0
|
0
|
-
|
|
| Total Liabilities |
2
|
17
|
0
|
-
|
|
| Total Current Liabilities |
1
|
1
|
1
|
-
|
|
| Long Term Debt |
0
|
16
|
-1
|
-
|
|
| Shareholder equity |
122
|
118
|
105
|
-
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | |
| Cash from Operations |
-4
|
-3
|
-
|
-
|
|
| Depreciation |
2
|
2
|
-
|
-
|
|
| Cash from Investing |
-1
|
-27
|
-
|
-
|
|
| Capex |
1
|
1
|
-
|
-
|
|
| Cash from Financing |
0
|
33
|
-
|
-
|
|
| Stock Issued |
0
|
8
|
-
|
-
|
|
| Debt (LT) Issued |
0
|
18
|
-
|
-
|
|
| Free Cash Flow |
-4
|
30
|
-
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | |
| Net Profit Margin |
-
|
-
|
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
6.2
|
15.0
|
64.5
|
-
|
|
| Financial Leverage D/E |
0.00
|
0.13
|
0.00
|
-
|
|
| Return on Capital Avg |
-5.1%
|
-3.0%
|
-
|
-
|
|
| Return on Shareholder Equity |
-
|
-
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available